References
- Stefani S. Emergence of multi-drug resistance Gram-positive bacteria and new active antibiotics. Curr Med Chem 2005; 4.
- Schito AM, Marchese A, Elkharrat D, Farrell DJ, and The PROTEKT Study Group. Comparative activity of telithromycin against macrolide-resistant isolates of Streptococcus pneumoniae: results of two years of the PRO-TEKT surveillance study. J Chemother 2004; 16 (1): 13-22.
- Del Grosso M, Scotto d'Ambruso A, Iannelli F, Pozzi G, Pantosti A. Tn2009, a Tn916-like element containing mef(E) in S.pneumoniae. Antimicrob Agents Chemother 2004; 48 (6): 2037-2042.
- Speirs KM, Zervos MJ. Telithromycin. Exp Rev Anti-infective Ther 2004; 2 (5): 685–693.
- Matic V, Kosowska K, Bozdogan B et al. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of ery-thromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. Antimicrob Agents Chemother 2004; 48: 4103–4112.
- Karchmer AW. Increased antibiotic resistance in respira-tory tract pathogens: PROTEKT US-an update. Clin Infect Dis 2004; 39: S142–150.
- Balfour JA, Figgitt DP - Telithromycin. Drugs 2001; 61: 815–29.
- Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiology 8th Ed 2003 ASM press Washington DC, USA.
- Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. CLSI M7-A6. CLSI, Wayne, PA, USA. 2005.
- Cascone C, Santagati M, Noviello S et al. Macrolide resistance genes in Italian clinical isolates of Streptococcus pyogenes Microb Drug Resist 2002; 88 (2): 129–132.
- McDougal LK, Tenover FC, Lee LN et al. Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycin-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1998; 42: 2312–2318.
- Pitcher DG, Sanders NA, Owen RJ. Rapid extraction of bacterial genomicDNA with guanidium thiocyanate. Lett Appl Microbiol 1989; 8: 151–156.
- Santagati M, Iannelli F, Cascone C et al. The novel conjugative transposon Tn1207.3 carries the macrolide efflux gene mef(A) in Streptococcus pyogenes. Microb Drug Resist 2003; 9: 243.
- Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33 (9): 2233–2239.
- Schito GC, Felmingham D and The PROTEKT Study Group. Susceptibility of Streptococcus pneumoniae isolates to penicillin, azithromycin and telithromycin. Abs n. C2-829 pag 100-44th ICAAC - Washington DC October 30, 2004.
- Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among iso-lates of Streptococcus pneumoniae from the PROTEKT sur-veillance study, and comparative in vitro activity of ketolide, telithromycin. J Antimicrob Chemother 2002; 50, Suppl. 51, 25-37.
- Marchese A, Tonoli E, Debbia EA, Schito GC. Macrolide resistance mechanisms and expression of pheno-types among Streptococcus pneumoniae circulating in Italy. J Antimicrob Chemother 1999; 44 (4): 461–464.
- Monaco M, Cavilli R, D'Ambrosio F, Del Grosso M, Pantosti A. Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy. J Antimicrob Chemother 2005; 55 (2): 256–259.
- Whitney CG, Farley MM, Hadler J et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. New Engl J Med 2000; 343: 1917–1924.
- Marchese AM, Tonoli E, Balistreri G, Debbia E, Schito GC. Antibiotic susceptibility patterns and serotypes of antibiot-ic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy. Microb Drug Resist 2000; 2: 163–169.
- Montanan MP, Cochetti I, Mongoia M, Varaldo PE. Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae. Antimicrob Agents Chemother 2003; 47: 2236–2241.
- Schmitz FJ, Perdikouli M, Beeck A, Verhoef J, Fluit AC. Resistance to trimethoprim-sulfamethoxazole and modifi-cations in genes coding for dihydrofolate reductase and dihy-dropteroate synthase in European Streptococcus pneumoniae isolates. J Antimicrob Chemother 2001; 48: 931–942.
- Brown SD, Farrell DJ, Morrisey I. Prevalence and mol-ecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 200-2001 PROTEKT US Study. J Clin Microbiol 2004; 42: 4980–4987.
- Montanan' MP, Tili E, Cochetti I, Mingoia M, Manzin A, Varaldo PE. Molecular characterization of clinical Streptococcus pneumoniae isolates with reduced susceptibility to fluoroquinolones emerging in Italy. Microb Drug Resist 2004; 10 (3): 209–217.